Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell, Circulating Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03917524
What this trial is testing

Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients.

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
Chang Gung Memorial Hospital 180
Not applicableStudy completedNCT02500693
What this trial is testing

Circulating Tumor Cells in Lung Cancer Screening

Who this might be right for
Lung NeoplasmsPulmonary Disease, Chronic Obstructive
Centre Hospitalier Universitaire de Nice 683
Not applicableStudy completedNCT03340844
What this trial is testing

Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors

Who this might be right for
Pancreatic TumorPeriampullary Carcinoma ResectableCirculating Tumor Cells+1 more
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 86
Not applicableWithdrawnNCT05244434
What this trial is testing

Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer

Who this might be right for
Advanced Breast AdenocarcinomaAdvanced HER2-Negative Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8+12 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT02958852
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Lund University Hospital 126
Not applicableUnknownNCT02422628
What this trial is testing

Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC

Who this might be right for
Lung Cancer
National Taiwan University Hospital 400
Not applicableStudy completedNCT02974764
What this trial is testing

Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma

Who this might be right for
Neoplastic Cells, CirculatingPancreatic CancerBiological Markers
Johns Hopkins University 200
Not applicableLooking for participantsNCT06488365
What this trial is testing

In Vivo Liquid Biopsy of Melanoma (Cytophone)

Who this might be right for
MelanomaCirculating Tumor CellsMetastatic Melanoma+1 more
Cytoastra 180
Testing effectiveness (Phase 2)Ended earlyNCT05245071
What this trial is testing

Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sanofi 22
Not applicableStudy completedNCT03311152
What this trial is testing

Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Central Hospital, Nancy, France 639
Not applicableLooking for participantsNCT04065321
What this trial is testing

Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer

Who this might be right for
Breast Neoplasms
Shengjing Hospital 500
Not applicableWithdrawnNCT02022904
What this trial is testing

Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology

Who this might be right for
Prostate Cancer
Duke University
Not applicableStudy completedNCT03935802
What this trial is testing

Analysis of Circulating Epithelial Tumor Cells in Peripheral Blood in Patients With Primary Non-metastatic Breast Cancer Under Adjuvant Radiotherapy

Who this might be right for
Breast Cancer Female
University of Jena 161
Testing effectiveness (Phase 2)Study completedNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 12
Not applicableLooking for participantsNCT06541080
What this trial is testing

Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium

Who this might be right for
Neuroendocrine Neoplasms
University Hospital, Antwerp 550
Not applicableLooking for participantsNCT06885879
What this trial is testing

Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Chinese University of Hong Kong 15
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Not applicableStudy completedNCT02251314
What this trial is testing

Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma

Who this might be right for
Melanoma
University Health Network, Toronto 12
Not applicableNot Yet RecruitingNCT06655142
What this trial is testing

OSCAR II STUDY - The ONCObind CTC Removal Study

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC)
ExThera Medical Corporation 120
Not applicableUnknownNCT04903990
What this trial is testing

Circulating Fetal Cells and Breast Cancer

Who this might be right for
Breast Cancer
Assistance Publique - Hôpitaux de Paris 80
Next Page